Clinical Report: Is Point-of-Care Hepatitis C Virus Testing Too Expensive?

Overview

Point-of-care RNA testing for hepatitis C virus could significantly increase hospital laboratory costs, with potential annual increases of $2.9 million for a three-hospital system. Despite the benefits of immediate treatment initiation, the financial implications pose challenges for healthcare systems.

Background

Hepatitis C virus (HCV) remains a major public health concern, with effective screening and treatment strategies essential for achieving elimination goals. The integration of point-of-care testing could enhance immediate treatment opportunities, but cost-effectiveness remains a critical issue. Understanding the financial impact of these testing strategies is vital for healthcare systems aiming to improve HCV management.

Data Highlights

Key Findings

• Point-of-care RNA testing could increase laboratory costs by up to 260%.
• Annual costs for implementing point-of-care RNA testing in a three-hospital system could reach $2.9 million.
• Emergency department testing for HCV increased by 682% from 2017 to 2024.
• The antibody positivity rate in the county hospital emergency department is 10.3%, compared to 2.7% in outpatient clinics.
• HCV antigen testing may be a cost-effective alternative, adding only $11,494 in annual costs.
• Current Medicare reimbursement rates do not reflect the actual costs of point-of-care RNA testing.

Clinical Implications

Suggest specific alternative strategies or examples of antigen testing to enhance completeness.

Conclusion

The financial burden of point-of-care RNA testing for hepatitis C virus poses significant challenges for healthcare systems. Strategic deployment and funding mechanisms are essential to support HCV elimination efforts without compromising other laboratory services.

References

1. University of Washington, Journal of Clinical Microbiology, 2023 -- Is Point-of-Care Hepatitis C Virus Testing Too Expensive?
2. The Journal of Infectious Diseases, 2023 -- Rapid Hepatitis C Virus RNA Testing at the Point of Care Achieves 15-Minute Results
3. Open Forum Infectious Diseases, 2023 -- Economic Evaluation of Various Hepatitis C Diagnosis and Treatment Strategies for Treatment-Naive Individuals Who Inject Drugs in Australia
4. The Journal of Infectious Diseases, 2023 -- Creation of a Quick Automated Point-of-Care Test for Hepatitis C Viral RNA Utilizing the DASH Rapid PCR System
5. CDC, Clinical Screening and Diagnosis for Hepatitis C, 2025 -- Current Guidance on HCV Testing
6. The New Gastroenterologist — Unfulfilled Potential of a Promising Hepatitis C Treatment
7. CDC Guidance on Hepatitis C Testing
8. Optimizing Hepatitis C Virus Testing